<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03872700</url>
  </required_header>
  <id_info>
    <org_study_id>2019-9925</org_study_id>
    <nct_id>NCT03872700</nct_id>
  </id_info>
  <brief_title>Intranasal Fentanyl as an Adjunct to Lidocaine Infiltration in Adults Undergoing Abscess Incision and Drainage</brief_title>
  <official_title>A Randomized Trial of Intranasal Fentanyl Versus Placebo as an Adjunct to Lidocaine Infiltration in Adults Undergoing Abscess Incision and Drainage in the Emergency</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Montefiore Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Montefiore Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This randomized clinical trial aims to compare the analgesic efficacy of intranasal fentanyl
      to placebo as analgesic adjunct to conventional local anesthesia for the treatment of pain of
      the overall procedure in adult patients undergoing lidocaine infiltration and subsequent
      abscess incision and drainage in the Emergency Department (ED).
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 1, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2022</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Numerical Rating Scale (NRS) pain score for overall procedure</measure>
    <time_frame>baseline</time_frame>
    <description>Pt reported pain scores for overall pain after dressing application. The NRS is a reliable and validated measure of pain intensity ranging from 0 - no pain, to 10 - worst pain imaginable.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>NRS pain score after abscess incision and drainage procedure</measure>
    <time_frame>baseline</time_frame>
    <description>Pt reported NRS pain scores after incision. The NRS is a reliable and validated measure of pain intensity ranging from 0 - no pain, to 10 - worst pain imaginable.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>NRS pain score after instrumentation and packing</measure>
    <time_frame>Up to 60 minutes as the time of completion of application of the bandage.</time_frame>
    <description>Pt reported pain after breaking of loculations, irrigation, and packing of abscess. The NRS is a reliable and validated measure of pain intensity ranging from 0 - no pain, to 10 - worst pain imaginable.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient reported outcome of satisfaction with treatment: Descriptive Scale</measure>
    <time_frame>120 minutes</time_frame>
    <description>Pt reported outcomes will be measured by patients response to feeling satisfied, neutral, not satisfied with treatment
Descriptive Scale: satisfied, neutral, not satisfied
*This is a non-numerical scale with 3 outcome response options as listed above. Satisfied is rated higher than neutral which is, in turn, rated higher than not satisfied.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health care providers reported perception of study medication compared to usual care</measure>
    <time_frame>120 minutes</time_frame>
    <description>Provider perception of better, same or worse treatment compared to usual care
Descriptive Scale: better, same, worse
*This is a non-numerical scale with 3 outcome response options as listed above. Better is rated higher than same which is, in turn, rated higher than worse.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Adverse events</measure>
    <time_frame>Up to 60 minutes</time_frame>
    <description>Incidence of adverse events</description>
  </other_outcome>
  <other_outcome>
    <measure>Side effects</measure>
    <time_frame>Up to 60 minutes</time_frame>
    <description>Incidence of side effects</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">162</enrollment>
  <condition>Abscess</condition>
  <arm_group>
    <arm_group_label>Intranasal fentanyl</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>2 mcg/kg INF, administered via intranasal route by atomizer syringe</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>0.04ml/kg of sterile water, administered via intranasal route by atomizer syringe</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Intranasal fentanyl</intervention_name>
    <description>Fentanyl Citrate</description>
    <arm_group_label>Intranasal fentanyl</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Sterile Water Up to 5Cc</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Presenting to the ED for an abscess requiring incision and drainage

          -  ED attending physician's judgment that the patient has capacity to provide informed
             consent.

          -  Patients must be able to understand English or Spanish.

        Exclusion Criteria:

          -  Use of opioids or tramadol within past 7 days.

          -  Prior adverse reaction or allergy to opioids.

          -  Patients who are pregnant

          -  Patients weight &gt; 100kg

          -  Chronic pain syndrome: frequently recurrent or daily pain for at least 3 months
             results in modulation of pain perception which is thought to be due to down-regulation
             of pain receptors. Examples of chronic pain syndromes include sickle cell anemia,
             osteoarthritis, fibromyalgia, and peripheral neuropathies.

          -  Medical condition that might affect metabolism or opioid analgesics such as cirrhosis
             (Child Pugh A or worse) or kidney impairment (CKD 3 or worse)

          -  Chronic malnutrition, severe hypovolemia (dehydration of blood loss) or hepatic
             disease

          -  Alcohol intoxication: history of alcoholism or the presence of alcohol intoxication as
             judged by the treating physician may alter pain perception and has previously
             increased adverse events.

          -  SBP &lt;100 mmHg: Opioids can produce peripheral vasodilation causing orthostasis.

          -  HR &lt; 60/min: Opioids can cause bradycardia.

          -  Oxygen saturation &lt; 95% on room air: For this study, oxygen saturation must be 95% or
             above on room air in order to be enrolled.

          -  Use of MAO inhibitors in past 30 days: MAO inhibitors have been reported to intensify
             the effects of at least one opioid drug causing anxiety, confusion and significant
             respiratory depression or coma.

          -  Patients using transdermal pain patches or oral opioid use &gt; 10 days in the prior
             month: frequent opioid use may influence both the amount of pain patients report as
             well as the level of relief they obtain from other treatments.

          -  Patients with a history of traumatic brain injury, seizures or hallucinations

          -  Patients with anatomical anomalies or medical conditions precluding intranasal
             administration
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>64 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Benjamin Friedman, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Montefiore Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Alexander V Latev, MD</last_name>
    <phone>4254437245</phone>
    <email>ALEXLATEV@GMAIL.COM</email>
  </overall_contact>
  <location>
    <facility>
      <name>Montefiore Medical Center</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10467</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Benjamin W Friedman, MD, MS</last_name>
      <phone>718-920-6626</phone>
      <email>befriedm@montefiore.org</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Halvorson GD, Halvorson JE, Iserson KV. Abscess incision and drainage in the emergency department--Part I. J Emerg Med. 1985;3(3):227-32.</citation>
    <PMID>4093575</PMID>
  </reference>
  <reference>
    <citation>Chudnofsky CR, Wright SW, Dronen SC, Borron SW, Wright MB. The safety of fentanyl use in the emergency department. Ann Emerg Med. 1989 Jun;18(6):635-9.</citation>
    <PMID>2729688</PMID>
  </reference>
  <reference>
    <citation>Qualls ML, Mooney MM, Camargo CA Jr, Zucconi T, Hooper DC, Pallin DJ. Emergency department visit rates for abscess versus other skin infections during the emergence of community-associated methicillin-resistant Staphylococcus aureus, 1997-2007. Clin Infect Dis. 2012 Jul;55(1):103-5. doi: 10.1093/cid/cis342. Epub 2012 Mar 28.</citation>
    <PMID>22460965</PMID>
  </reference>
  <reference>
    <citation>Rupp T, Delaney KA. Inadequate analgesia in emergency medicine. Ann Emerg Med. 2004 Apr;43(4):494-503. Review.</citation>
    <PMID>15039693</PMID>
  </reference>
  <reference>
    <citation>Brown JC, Klein EJ, Lewis CW, Johnston BD, Cummings P. Emergency department analgesia for fracture pain. Ann Emerg Med. 2003 Aug;42(2):197-205.</citation>
    <PMID>12883507</PMID>
  </reference>
  <reference>
    <citation>Lewis LM, Lasater LC, Brooks CB. Are emergency physicians too stingy with analgesics? South Med J. 1994 Jan;87(1):7-9.</citation>
    <PMID>8284721</PMID>
  </reference>
  <reference>
    <citation>Schmitz G, Goodwin T, Singer A, Kessler CS, Bruner D, Larrabee H, May L, Luber SD, Williams J, Bhat R. The treatment of cutaneous abscesses: comparison of emergency medicine providers' practice patterns. West J Emerg Med. 2013 Feb;14(1):23-8. doi: 10.5811/westjem.2011.9.6856.</citation>
    <PMID>23447753</PMID>
  </reference>
  <reference>
    <citation>Bourne CL, Brewer KL, House J. Injectable lidocaine provides similar analgesia compared to transdermal lidocaine/tetracaine patch for the incision and drainage of skin abscesses: a randomized, controlled trial. J Emerg Med. 2014 Sep;47(3):367-71. doi: 10.1016/j.jemermed.2013.11.126. Epub 2014 May 14.</citation>
    <PMID>24835497</PMID>
  </reference>
  <reference>
    <citation>Chang AK, Bijur PE, Baccelieri A, Gallagher EJ. Efficacy and safety profile of a single dose of hydromorphone compared with morphine in older adults with acute, severe pain: a prospective, randomized, double-blind clinical trial. Am J Geriatr Pharmacother. 2009 Feb;7(1):1-10. doi: 10.1016/j.amjopharm.2009.02.002.</citation>
    <PMID>19281935</PMID>
  </reference>
  <reference>
    <citation>Chang AK, Bijur PE, Davitt M, Gallagher EJ. Randomized clinical trial of an intravenous hydromorphone titration protocol versus usual care for management of acute pain in older emergency department patients. Drugs Aging. 2013 Sep;30(9):747-54. doi: 10.1007/s40266-013-0103-y.</citation>
    <PMID>23846749</PMID>
  </reference>
  <reference>
    <citation>Singer AJ, Richman PB, Kowalska A, Thode HC Jr. Comparison of patient and practitioner assessments of pain from commonly performed emergency department procedures. Ann Emerg Med. 1999 Jun;33(6):652-8.</citation>
    <PMID>10339680</PMID>
  </reference>
  <reference>
    <citation>McNamara RM, Rousseau E, Sanders AB. Geriatric emergency medicine: a survey of practicing emergency physicians. Ann Emerg Med. 1992 Jul;21(7):796-801.</citation>
    <PMID>1610035</PMID>
  </reference>
  <reference>
    <citation>Potter M, Schafer S, Gonzalez-Mendez E, Gjeltema K, Lopez A, Wu J, Pedrin R, Cozen M, Wilson R, Thom D, Croughan-Minihane M. Opioids for chronic nonmalignant pain. Attitudes and practices of primary care physicians in the UCSF/Stanford Collaborative Research Network. University of California, San Francisco. J Fam Pract. 2001 Feb;50(2):145-51.</citation>
    <PMID>11219563</PMID>
  </reference>
  <reference>
    <citation>Petrack EM, Christopher NC, Kriwinsky J. Pain management in the emergency department: patterns of analgesic utilization. Pediatrics. 1997 May;99(5):711-4.</citation>
    <PMID>9113948</PMID>
  </reference>
  <reference>
    <citation>Borland M, Milsom S, Esson A. Equivalency of two concentrations of fentanyl administered by the intranasal route for acute analgesia in children in a paediatric emergency department: a randomized controlled trial. Emerg Med Australas. 2011 Apr;23(2):202-8. doi: 10.1111/j.1742-6723.2011.01391.x. Epub 2011 Feb 8.</citation>
    <PMID>21489168</PMID>
  </reference>
  <reference>
    <citation>Panagiotou I, Mystakidou K. Intranasal fentanyl: from pharmacokinetics and bioavailability to current treatment applications. Expert Rev Anticancer Ther. 2010 Jul;10(7):1009-21. doi: 10.1586/era.10.77. Review.</citation>
    <PMID>20645689</PMID>
  </reference>
  <reference>
    <citation>Paech MJ, Lim CB, Banks SL, Rucklidge MW, Doherty DA. A new formulation of nasal fentanyl spray for postoperative analgesia: a pilot study. Anaesthesia. 2003 Aug;58(8):740-4.</citation>
    <PMID>12859464</PMID>
  </reference>
  <reference>
    <citation>Veldhorst-Janssen NM, Fiddelers AA, van der Kuy PH, Kessels AG, Theunissen HM, van der Hulst RR, Neef C, Marcus MA. Pharmacokinetics, analgesic effect, and tolerability of a single preprocedural dose of intranasal fentanyl in patients undergoing drain removal after breast reduction or augmentation surgery: A prospective, randomized, double-blind, placebo-controlled study. Clin Ther. 2010 Jul;32(7):1427-36. doi: 10.1016/j.clinthera.2010.07.001.</citation>
    <PMID>20678689</PMID>
  </reference>
  <reference>
    <citation>Toussaint S, Maidl J, Schwagmeier R, Striebel HW. Patient-controlled intranasal analgesia: effective alternative to intravenous PCA for postoperative pain relief. Can J Anaesth. 2000 Apr;47(4):299-302.</citation>
    <PMID>10764171</PMID>
  </reference>
  <reference>
    <citation>Barrett MJ, Cronin J, Murphy A, McCoy S, Hayden J, an Fhailí S, Grant T, Wakai A, McMahon C, Walsh S, O'Sullivan R. Intranasal fentanyl versus intravenous morphine in the emergency department treatment of severe painful sickle cell crises in children: study protocol for a randomised controlled trial. Trials. 2012 May 30;13:74. doi: 10.1186/1745-6215-13-74.</citation>
    <PMID>22647439</PMID>
  </reference>
  <reference>
    <citation>Sutter ME, Wintemute GJ, Clarke SO, Roche BM, Chenoweth JA, Gutierrez R, Albertson TE. The Changing Use of Intravenous Opioids in an Emergency Department. West J Emerg Med. 2015 Dec;16(7):1079-83. doi: 10.5811/westjem.2015.10.28454. Epub 2015 Dec 14.</citation>
    <PMID>26759658</PMID>
  </reference>
  <reference>
    <citation>Imamoglu M, Aygun A, Bekar O, Erdem E, Cicek M, Tatli O, Karaca Y, Sahin A, Turkmen S, Turedi S. A retrospective analysis of nebulized versus intravenous fentanyl for renal colic. Am J Emerg Med. 2017 May;35(5):757-763. doi: 10.1016/j.ajem.2017.01.026. Epub 2017 Jan 15.</citation>
    <PMID>28119014</PMID>
  </reference>
  <reference>
    <citation>Price DD, Finniss DG, Benedetti F. A comprehensive review of the placebo effect: recent advances and current thought. Annu Rev Psychol. 2008;59:565-90. Review.</citation>
    <PMID>17550344</PMID>
  </reference>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>January 24, 2019</study_first_submitted>
  <study_first_submitted_qc>March 12, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 13, 2019</study_first_posted>
  <last_update_submitted>March 4, 2020</last_update_submitted>
  <last_update_submitted_qc>March 4, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 6, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Montefiore Medical Center</investigator_affiliation>
    <investigator_full_name>Benjamin W. Friedman, MD</investigator_full_name>
    <investigator_title>Professor, Emergency Medicine</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Abscess</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fentanyl</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

